Contract V797D30107
Mylan Pharmaceuticals Inc · Department Of Veterans Affairs · September 30, 2020
Mylan Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on September 30, 2020 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 17, 2021. If all options are exercised, the contract could reach $2.80 billion.
Contract details
- PIID
- V797D30107
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 30, 2020
- Latest action
- September 17, 2021
Description
NEW POC PHONE NUMBER
Modification timeline
-
September 17, 2021Mod P00190 · Other Administrative Action$0
-
September 17, 2021Mod P00189 · Supplemental Agreement For Work Within ScopeFCP TEMP FORMOTEROL FUMARATE INHALATION SOLUTION / 20 MCG/2 ML VIAL$0
-
September 17, 2021Mod P00188 · Supplemental Agreement For Work Within ScopeTPR -HYDROXYCHLOROQUINE SULFATE TABLETS 200MG 100S$0
-
September 30, 2020Mod P00165 · Supplemental Agreement For Work Within ScopeNDC AND EVEROLIMUS TABLETS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797D30107?
Contract V797D30107 is a federal contract awarded to Mylan Pharmaceuticals Inc by Department Of Veterans Affairs on September 30, 2020 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract V797D30107?
Mylan Pharmaceuticals Inc won contract V797D30107 from Department Of Veterans Affairs.
How much is contract V797D30107 worth?
Contract V797D30107 has obligated $0 to date but carries a potential ceiling of $2.80 billion if fully funded and all options are exercised.